| CIRRX | RYCRX | CIRRX / RYCRX | |
| Total Expense Ratio | 1.25 | 2.38 | 53% |
| Annual Report Gross Expense Ratio | 1.25 | 2.43 | 51% |
| Fund Existence | 12 years | 23 years | - |
| Gain YTD | 14.865 | 11.009 | 135% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 9.87B | 4.21M | 234,434% |
| Annual Yield % from dividends | 1.39 | 3.95 | 35% |
| Returns for 1 year | 14.19 | 11.09 | 128% |
| Returns for 3 years | 40.20 | 33.21 | 121% |
| Returns for 5 years | 8.30 | 2.56 | 324% |
| Returns for 10 years | 57.17 | 34.71 | 165% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GOIOX | 39.20 | 0.47 | +1.21% |
| JHancock International Growth 1 | |||
| WENRX | 65.98 | 0.49 | +0.75% |
| Allspring Mid Cap Growth Fund - Cl R6 | |||
| RYVLX | 842.17 | 5.14 | +0.61% |
| Rydex NASDAQ-100® 2x Strategy A | |||
| LVPSX | 105.96 | 0.51 | +0.48% |
| ProFunds Large Cap Value Svc | |||
| ARIGX | 15.92 | 0.05 | +0.32% |
| Aristotle Growth Equity I | |||